Welgene Biotech Co.,Ltd.
Research Welgene Biotech Co.,Ltd. (6661.TWO) on Bullrun: market cap TWD 396.17M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6661.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyTWD
- Market capTWD 396.17M
- Financial periodQ2 2026
- RevenueTWD 107.21M
- Net income-TWD 1.71M
- Free cash flow-TWD 58.44M
- Gross margin40.3%
Valuation Snapshot
latest market cap is TWD 396.17M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 396.17M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Welgene Biotech Co.,Ltd.
Welgene Biotech Co.,Ltd. engages in the trade of biotechnology-related instruments, reagents, and biotechnology testing services. The company offers research services, including generation, PacBio third generation sequencing; microarray, protein body analysis; nucleic acid extraction/QC, single cell experimental, and bioinformatics analysis services. It also provides reagents, medical consumables, and instruments, as well as software services. Welgene Biotech Co.,Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Welgene Biotech Co.,Ltd.'s market cap?
Welgene Biotech Co.,Ltd.'s market capitalization is TWD 396.17M.
What does Welgene Biotech Co.,Ltd. do?
Welgene Biotech Co.,Ltd. engages in the trade of biotechnology-related instruments, reagents, and biotechnology testing services. The company offers research services, including generation, PacBio third generation sequencing; microarray, protein body analysis; nucleic acid extraction/QC, single cell experimental, and bioinformatics analysis services. It also provides reagents, medical consumables, and instruments, as well as software services. Welgene Biotech Co.,Ltd. was founded in 2003 and is based in Taipei City, Taiwan.